Key Finding
No strong consistent positive evidence pattern was detected.
Interventions with strongest consistent evidence
Strongest consistent evidence
Interpretation
The current evidence does not yet show a clear consistent-benefit pattern.
Bone Mineral Density in Diabetes Evidence
Evidence on improving bone mineral density
Evidence related to bone mineral density and bone mineral content outcomes in diabetes studies.
Crea tu Evidence Workspace
Guarda evidencia sobre los temas que te importan.
6
Studies
10
Evidence Pairs
Limited Research
Evidence Base: 23/100
Evidence Intelligence™
Evidence Summary
A structured summary of where the evidence is strongest, mixed, or still emerging.
Executive Summary
Bone Mineral Density evidence appears to center on Eldecalcitol.
Among 6 indexed studies and 7 interventions, the strongest signals are summarized from the available evidence. Dapagliflozin has been studied often, while Eldecalcitol appears to have stronger current evidence signals.
- No strong consistent positive evidence pattern was detected.
- Some evidence is positive, but results are not consistent across all studies.
- Early findings are encouraging, but stronger trials are needed.
Caution
This summary reflects the currently indexed evidence and should not be interpreted as treatment advice.
Evidence Snapshot
6
Studies
7
Interventions
4
Outcomes
0
Strong evidence signals
0
Mixed evidence areas
Key Findings
Key patterns and insights identified across the research landscape
Strong positive signal
Vitamin D supplementation shows strong evidence for improving Bone mineral content (BMC)
Vitamin D supplementation → Bone mineral content (BMC)
Across 1 study, Vitamin D supplementation shows a strong positive signal for Bone mineral content (BMC).
1 studies
EvidenceScore™: 59/100
Neutral signal
Dapagliflozin shows limited or neutral effect on Bone mineral density (BMD)
Dapagliflozin → Bone mineral density (BMD)
Across 1 study, Dapagliflozin shows a neutral signal for Bone mineral density (BMD).
1 studies
EvidenceScore™: 59/100
Strong positive signal
Eldecalcitol shows strong evidence for improving Bone mineral density (BMD)
Eldecalcitol → Bone mineral density (BMD)
Across 1 study, Eldecalcitol shows a strong positive signal for Bone mineral density (BMD).
1 studies
EvidenceScore™: 59/100
Evidence signal
Gastric bypass shows evidence for Bone mineral density (BMD)
Gastric bypass → Bone mineral density (BMD)
Across 1 study, Gastric bypass shows a evidence signal for Bone mineral density (BMD).
1 studies
EvidenceScore™: 59/100
Evidence signal
Insulin therapy shows evidence for Bone mineral density (BMD)
Insulin therapy → Bone mineral density (BMD)
Across 1 study, Insulin therapy shows a evidence signal for Bone mineral density (BMD).
1 studies
EvidenceScore™: 59/100
Supporting Evidence
Mixed or conflicting evidence
Some evidence is positive, but results are not consistent across all studies.
Areas where results are mixed
Why it matters
Mixed results suggest effects may depend on population, comparator, duration, or study design.
Interpretation
MyPlan 2.0 is mixed in the currently indexed evidence.
Caution
Some supporting studies reported neutral, negative, or mixed findings.
Top entities
MyPlan 2.0
MyPlan 2.0
1 study
EvidenceScore™
59/100
ConsistencyScore™
100/100
Why this appears here
Mixed Or Conflicting ResultsPositive Signal PresentNeutral Results Present
Evidence basis: 1 evidence pair - 1 study
Promising but understudied
Early findings are encouraging, but stronger trials are needed.
Promising areas needing more evidence
Why it matters
Promising signals can guide further review, but they should not be treated as settled evidence.
Interpretation
Eldecalcitol may have a beneficial signal, but the evidence base is still developing.
Caution
Current support is limited by study volume, RCT depth, or evidence strength.
Top entities
Eldecalcitol
MyPlan 2.0
Eldecalcitol
1 study
EvidenceScore™
59/100
ConsistencyScore™
100/100
Why this appears here
Positive effect signalLimited study volumeFew randomized trialsEmerging Or Limited Strength
Evidence basis: 4 evidence pairs - 3 studies
Explore the Evidence
The sections below provide the complete evidence questions, supporting relationships, and underlying studies behind the summary above.
Preguntas respondidas por la evidencia
What improves bone mineral density?
outcome achievementEmerging Evidence
Dapagliflozin, Eldecalcitol, and Gastric bypass are among the most studied approaches for Bone Mineral Density.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
Vitamin D supplementation
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
- 2
Eldecalcitol
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
- 3
MyPlan 2.0
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on 6 supporting studies and existing graph evidence signals.
Limitations
- Consistency cannot yet be determined.
- Population details are unavailable.
Does Dapagliflozin improve bone mineral density?
intervention effectivenessEmerging Evidence
Current evidence does not show a clear benefit of Dapagliflozin for Bone mineral density (BMD).
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
Dapagliflozin
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
- Consistency cannot yet be determined.
- Population details are unavailable.
Does Eldecalcitol improve bone mineral density?
intervention effectivenessEmerging Evidence
Eldecalcitol appears to improve Bone mineral density (BMD).
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
Eldecalcitol
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
- Consistency cannot yet be determined.
- Population details are unavailable.
Does Gastric bypass improve bone mineral density?
intervention effectivenessEmerging Evidence
Gastric bypass may worsen Bone mineral density (BMD) or be associated with harm.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
Gastric bypass
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | moderate negative | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
- Consistency cannot yet be determined.
- Population details are unavailable.
Dapagliflozin vs Eldecalcitol for bone mineral density?
compareEmerging Evidence
Dapagliflozin and Eldecalcitol have available evidence for Bone Mineral Density, but the comparison requires review of the underlying studies.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
Eldecalcitol
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
- 2
Dapagliflozin
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a small number of supporting studies and should be interpreted cautiously.
Limitations
- Only a small number of supporting studies are available.
- Consistency cannot yet be determined.
- Population details are unavailable.
How can I lower bone mineral density (bmd)?
sub outcomeEmerging Evidence
Dapagliflozin, Eldecalcitol, and Gastric bypass are among the most studied approaches for Bone mineral density (BMD).
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
Eldecalcitol
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
- 2
Vitamin D supplementation
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
- 3
Dapagliflozin
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on 5 supporting studies and existing graph evidence signals.
Limitations
- Consistency cannot yet be determined.
- Population details are unavailable.
Evidence summary for AI and search
Among 6 indexed studies and 7 interventions, the strongest signals are summarized from the available evidence. Dapagliflozin has been studied often, while Eldecalcitol appears to have stronger current evidence signals.
- No strong consistent positive evidence pattern was detected.
- Some evidence is positive, but results are not consistent across all studies.
- Early findings are encouraging, but stronger trials are needed.
Supporting Research
Selected studies that best represent the evidence behind this topic.
Eldecalcitol may reduce diabetes risk in pre-diabetics with low insulin
Representative
Interventions:
Outcomes:
Gastric Bypass Linked to Greater Bone Loss than Sleeve Gastrectomy
Representative
Interventions:
Outcomes:
Metabolic dysfunction linked to musculoskeletal issues in obesity.
Representative
Interventions:
Outcomes:
Click any study to view the full research summary, or click interventions and outcomes to filter Evidence Explorer.
Evidence Tracker
Track Bone Mineral Density in Diabetes Evidence evidence
Save this evidence topic and revisit it as new studies are added.